Yutiq: The 3-Year Steroid Implant for Chronic Uveitis
Yutiq: What It Is and What to Expect
Yutiq is a tiny steroid implant, smaller than a grain of rice, that your eye doctor places inside your eye to calm chronic uveitis (long-lasting inflammation inside the eye). It slowly releases a low dose of a steroid for up to about three years, which helps prevent the flare-ups that can threaten your sight1. The main trade-off is that this kind of long-acting steroid tends to speed up cataracts and can raise eye pressure, both of which your doctor watches for and can manage. For many people with hard-to-control uveitis, that trade-off is worth fewer flare-ups.
Uveitis that keeps coming back is usually treated with steroid drops, injections, or pills, but those wear off or carry whole-body side effects. Yutiq is different: it is a single, long-lasting source of steroid placed right where it is needed. It is designed to deliver steady, local anti-inflammatory treatment for about three years so you need fewer repeat injections and less steroid for your whole body1. It treats the inflammation; it does not cure the underlying cause of your uveitis.
If your specialist has suggested Yutiq, the useful next step is a frank conversation about the trade-offs. Ask whether you still have your natural lens (if so, expect a cataract over time), what your current eye pressure is, and how often you will be monitored. Yutiq should not be placed if you have an active eye infection, so your doctor will make sure your eye is free of infection first1. Bring your list of eye conditions and medicines to that visit.
What Yutiq Is and How It Works
Yutiq is a micro-insert containing fluocinolone acetonide 0.18 mg, a corticosteroid. It is a non-dissolving implant that releases a low daily dose of steroid into the eye for about 36 months, roughly three years, and is placed through a thin 25-gauge needle in the office, with no surgical cut1. Because it does not dissolve, it stays in the eye after the medicine runs out, though it causes no problems sitting there.
Yutiq is made for one specific job. It is FDA-approved to treat chronic non-infectious uveitis affecting the back part of the eye, the posterior segment1. 'Non-infectious' matters: it is used when the inflammation is driven by the immune system, not by an active infection, because a steroid can make an untreated eye infection worse. Your doctor confirms the type of uveitis before choosing it.
Uveitis flares happen when inflammation returns inside the eye. A steady, low dose of local steroid keeps that inflammation quiet. By releasing steroid continuously for about three years, the implant aims to reduce how often uveitis comes back and to spare you repeated injections and whole-body steroid side effects1. It works locally, so the amount of steroid reaching the rest of your body is small compared with steroid pills.
How the Implant Is Placed
Placing Yutiq is a quick office procedure, not an operation in a hospital. Your doctor numbs the eye with drops, cleans the surface with an antiseptic to lower infection risk, and injects the implant through a fine needle into the vitreous, the jelly that fills the eye. The implant is delivered through a 25-gauge applicator using a sterile technique, without an incision1. The injection itself takes only a moment.
Most people feel pressure rather than sharp pain, thanks to the numbing drops, and the eye may be a little gritty, red, or watery for a day or two afterward. You might see new floaters at first. These usually settle on their own. Because any eye injection carries a small risk of infection or other problems, you will be told the warning signs to watch for and when to call3. Most people return to normal activities quickly.
How Well It Works
The implant was tested against a sham (inactive) procedure in people with chronic uveitis. In the main trial, a uveitis flare-up within six months happened in about 18 of every 100 eyes that got the implant, compared with about 79 of every 100 that got the sham1. A published analysis of the same trial confirmed that flare-ups were far less common with the implant than without it2. In plain terms, most implanted eyes stayed quiet where most untreated eyes flared.
Each uveitis flare can blur vision and, over time, cause lasting damage, so preventing flares protects sight. By cutting the flare rate substantially over three years, the implant is intended to keep the eye quieter and reduce the need for rescue treatment2. It does not work for everyone, and some eyes still flare, but for many people it means fewer bad days and fewer emergency visits. Your doctor tracks how your eye responds.
Side Effects, Risks, and the Trade-Offs
These are the effects to understand before you agree, and they are the same for all long-acting eye steroids. Cataract (clouding of the eye's natural lens) developed in about 56 of every 100 implanted eyes in the first year, versus about 23 of 100 sham eyes1. Eye pressure rose by a meaningful amount in about 22 of 100 implanted eyes, roughly 43 of 100 needed pressure-lowering drops at some point, and about 2 of 100 needed surgery to control pressure1. The reassuring side: cataracts are fixable with routine surgery, and raised pressure is usually controlled with drops.
Beyond the steroid effects, the injection carries its own small risks. These include infection inside the eye (endophthalmitis), inflammation, a rise in eye pressure, retinal detachment, and floaters1. Serious problems are uncommon, and the antiseptic prep is done specifically to keep infection rare. Knowing the warning signs (below) means that if something does go wrong, it is caught and treated early.
Plan for regular check-ups rather than a one-and-done fix. Your doctor will measure your eye pressure and check your lens at scheduled visits, because both cataract and pressure changes build slowly and quietly. If you still have your natural lens, expect that a cataract may form over the implant's life and may eventually need surgery1. If you have already had cataract surgery, that particular trade-off does not apply to you.
Some soreness or a few floaters right after the injection can be normal, but certain signs are not and need same-day attention. Call your eye doctor immediately, or go to an emergency room if you cannot reach them, for any of these in the days after the injection:
- Eye pain that keeps getting worse instead of better
- Increasing redness, or pus or discharge from the eye
- A drop in your vision, or a sudden increase in floaters or flashes
These can signal an infection inside the eye, which is rare but treatable when caught early, so it is always safer to call than to wait.
Who Should Not Have It, or Should Wait
There are clear situations where the implant is not appropriate. Yutiq should not be used if you have an active eye or nearby infection, including most viral infections of the cornea such as active herpes, or if you are allergic to any part of the product1. This is why your doctor confirms your uveitis is non-infectious and your eye is currently free of infection before placing it.
Some conditions call for extra care rather than an outright no. Because the steroid can raise eye pressure, people with glaucoma or a tendency to pressure spikes need close monitoring, and a history of eye herpes calls for caution1. None of these automatically rules you out, but they change how carefully you are watched and may affect whether the implant is the best choice for you. Share your full eye history with your specialist.
How Yutiq Compares to Other Steroid Implants
Yutiq is one of several steroid implants, and they differ mainly in the steroid used, the dose, and how long they last. The figures below come from each product's FDA information.
| Implant | Steroid and dose | About how long it lasts |
|---|---|---|
| Yutiq | Fluocinolone acetonide 0.18 mg | About 3 years (uveitis) |
| Iluvien | Fluocinolone acetonide 0.19 mg | About 3 years |
| Retisert | Fluocinolone acetonide 0.59 mg | About 2.5 years (placed by surgery) |
| Ozurdex | Dexamethasone 0.7 mg | About 3 to 6 months (dissolves) |
Retisert holds more steroid and is placed surgically4, Iluvien is a closely related fluocinolone implant6, and Ozurdex uses a different steroid that dissolves and lasts only months, so it is repeated more often5.
The choice depends on your condition and eye. Yutiq offers about three years of coverage from an in-office injection without surgery, which can suit chronic uveitis that keeps returning1. A shorter-acting option like the dexamethasone implant may be preferred when a doctor wants a briefer course5, while Iluvien is a closely related fluocinolone implant first approved for diabetic macular edema6. Your specialist matches the implant to how long and how strongly your eye needs treatment.
When to See a Doctor
After the implant is placed, treat these as same-day emergencies and call your eye doctor or go to an emergency room:
- Worsening eye pain, spreading redness, or discharge
- A drop or loss of vision
- A sudden increase in floaters or new flashing lights
These can point to an infection or a retinal problem, both of which do best when treated quickly.
Other changes are less urgent but still worth a prompt call to your eye team:
- Gradually blurrier vision, which may be a cataract forming
- Mild aching, or the feeling that your eye pressure is off, between visits
- Any question about your monitoring schedule or drops
Because raised eye pressure is usually silent, do not wait to feel unwell. Keep your scheduled pressure checks even when your eye feels fine.
Most of your care is scheduled monitoring. Keep every follow-up so your doctor can measure eye pressure and check your lens over the implant's three-year life. Between visits, watch for the urgent signs above. If your eye is comfortable and your vision steady, your routine checks are enough.
Yutiq is placed and managed by an ophthalmologist, usually a uveitis or retina specialist. For a sudden, painful, or vision-threatening problem, contact that specialist the same day, or use an emergency room if you cannot reach them. Your regular eye doctor and specialist coordinate your ongoing pressure and cataract monitoring.
Common Questions About Yutiq
Yutiq is a tiny steroid implant for chronic uveitis. It contains fluocinolone acetonide 0.18 mg and slowly releases steroid inside the eye for about three years to prevent uveitis flare-ups, and it is placed by injection in the office1. It treats the inflammation rather than curing the cause. The main things to weigh are its two common trade-offs, cataract and raised eye pressure, both of which your doctor monitors and can manage.
Usually not much. The eye is numbed with drops first, so most people feel pressure or a brief sting rather than sharp pain. The implant goes in through a fine 25-gauge needle without any surgical cut, and the injection takes only a moment1. Afterward the eye may feel gritty or look red for a day or two, and you may notice floaters, which typically settle. Tell your doctor if pain grows rather than eases.
It cuts flare-ups substantially for most people. In the main trial, about 18 of every 100 implanted eyes flared within six months, versus about 79 of every 100 that got a sham procedure1. That is a large difference, though it is not a guarantee: some eyes still flare, and the implant does not fix the underlying condition. Your specialist tracks your response and adds other treatment if needed.
If you still have your natural lens, quite possibly, over time. Cataract developed in about 56 of every 100 implanted eyes in the first year, compared with about 23 of 100 sham eyes, which is expected with all long-acting eye steroids1. The reassuring part is that cataracts are treated with routine, highly effective surgery. If you have already had cataract surgery, this trade-off does not apply to you.
It can raise pressure in some people, which is why monitoring matters. Eye pressure rose meaningfully in about 22 of 100 implanted eyes, about 43 of 100 needed pressure-lowering drops at some point, and roughly 2 of 100 needed surgery for pressure1. Raised pressure is usually silent, so you cannot feel it, and scheduled checks are how it is caught. For most people it is controlled with drops before it can harm the optic nerve.
Possibly, depending on your uveitis. The implant releases steroid for about three years, after which its effect fades, and the empty implant stays harmlessly in the eye1. If your inflammation is still active as the effect wears off, your doctor may recommend another implant or a different treatment. If your uveitis has become quiet, you may not need one. Your specialist decides based on how your eye is doing.
More Questions, and Where These Answers Come From
They are all steroid implants but differ in dose, lasting time, and how they are placed. Ozurdex uses dexamethasone, dissolves, and lasts only about 3 to 6 months, so it is repeated more often, while Retisert holds more fluocinolone (0.59 mg) and is placed surgically4. Yutiq sits in between: a long, roughly three-year course from a simple office injection. Your doctor picks based on how long and how strong a treatment your eye needs.
Yes. Yutiq is FDA-approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, and it was approved in 20181. Being approved means it was reviewed for safety and effectiveness for that specific use. It is not approved for infectious uveitis or for other eye conditions, which is why your doctor confirms your diagnosis before choosing it.
Call the same day for worsening pain, spreading redness, discharge, a drop in vision, or a sudden burst of new floaters or flashes. These can signal an infection inside the eye, which is rare but treatable when caught early3. A little soreness or a few floaters that settle within a day or two are usually normal. When in doubt, call: it is always safer to be checked.
These questions help you weigh the implant for your own eye:
- Do I still have my natural lens, and if so, how likely am I to need cataract surgery?
- What is my eye pressure now, and how often will it be checked?
- What are my alternatives to Yutiq, and why do you recommend this one?
- What exactly should make me call you the same day after the injection?
- What is the plan when the implant's effect wears off in about three years?
- YUTIQ (fluocinolone acetonide intravitreal implant) 0.18 mg Prescribing Information. FDA label via DailyMed (U.S. NLM). Dose, duration, indication, recurrence data, cataract and eye-pressure rates, contraindications.
- Jaffe GJ, et al. Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis: Twelve-Month Results. Ophthalmology (2019). Pivotal trial showing reduced uveitis recurrence.
- American Academy of Ophthalmology (EyeSmart). What Is Endophthalmitis? Warning signs of infection after an eye injection.
- RETISERT (fluocinolone acetonide intravitreal implant) 0.59 mg Prescribing Information. FDA label via DailyMed. Surgically placed uveitis implant for comparison.
- OZURDEX (dexamethasone intravitreal implant) 0.7 mg Prescribing Information. FDA label via DailyMed. Shorter-acting, bioerodible steroid implant for comparison.
- Syed YY. Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN): A Review in Diabetic Macular Edema. Drugs (2017). Comparator implant approved for diabetic macular edema.